About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Child and Adolescent Psychopharmacology
›
Top Articles
Journal of Child and Adolescent Psychopharmacology
Pediatrics
,
Psychiatry
,
Pharmacology
2.9
(top 6%)
Impact Factor
3.3
(top 6%)
extended IF
86
(top 4%)
H-Index
777
authors
2.2K
papers
49.7K
citations
2.9K
citing journals
14.2K
citing authors
Most Cited Articles of Journal of Child and Adolescent Psychopharmacology
Title
Year
Citations
Functional impairment in children and adolescents with obsessive-compulsive disorder
2003
379
DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls
2002
240
A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents
2003
224
Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version
2004
219
The presentation of anxiety in children with pervasive developmental disorders
2005
204
Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder
2000
189
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents
2011
184
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder
2009
181
Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality
2002
180
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders
2006
174
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data
2007
173
Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations
2006
167
Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference
2015
165
A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment
2008
164
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder
2001
161
Medication patterns in patients with autism: temporal, regional, and demographic influences
2005
147
An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder
2007
146
Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders
2013
144
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder
2009
142
Calming effects of deep touch pressure in patients with autistic disorder, college students, and animals
1992
141
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder
2006
140
Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression
2003
140
Neurobiological substrates of Tourette's disorder
2010
139
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
2003
138
Medication use among children with autism spectrum disorders
2007
136
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.